Merck funds Bionomics with $20 million to progress therapies for cognitive impairment caused by central nervous system disorders

The collaboration will use Mersana Therapeutics Fleximer technology for antibody-drug conjugates.

European Medicines Agency clarifies advanced-therapy medicinal products classification.

Bristol-Myers Squibb issues a voluntary US recall of Coumadin (warfarin sodium) for injection due to presence of particulate matter.

Biotage has launched a purification technology, Accelerated Chromatographic Isolation (ACI), which converts simple flash purification into a faster and more economical way to isolate pure compounds.

This work marks the first joint project between regulators and HTA bodies on a European level and is part of their ongoing dialogue to support policymaker decisions in the future.

Onyx Scientific has announced plans to invest in continuous flow manufacturing to allow its customers to explore alternatives during product research and development programs.

PolySciTech's new launch, SpinSwiper, has the potential to speed up microparticle production.

GSK and Save the Children announce criteria for awards that recognize innovation in healthcare for the world&s poorest children.

Covance MarketPlace is designed to enable partnerships between the company';s emerging biotechnology and established pharmaceutical clients.

Cytovance Biologics completes GMP manufacture of ARMO BioSciences& lead product.

Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China&s Food and Drug Administration's shortened serialization deadline.

Frontage Labs will expand its CMC facility in Exton, PA.

GSK Biologicals receives warning about cGMP compliance issues at its Quebec facility.

Novartis' 13th Annual Malaria Expert Panel focused on access to quality anti-malarials across Africa.

Rentschler plans to build two stainless-steel bioreactors to target market supply.

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

Recipharm and CTC will offer packages for Phase I studies.

SGS introduces the Cobas 6000 Analyzer System for its France-based laboratory.

Jones Packaging introduces a new solid dose vial line in its Toronto facility.

According to the National Bioscience Report, the US bioscience industry is on course for continued growth.

Abbott will acquire a controlling interest in the Russian pharmaceutical manufacturer Veropharm.

FDA approved Cubist's treatment for skin infections including MRSA.

NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.

Shire reports that AbbVie offer undervalued company.

Dr. Reddy's recalls blood pressure drug due to failed dissolution tests.

FDA cites cGMP violations for API manufacturing at a facility in Tianjin, China.

Big pharma employment dropped by 3% between 2003 and 2013, according to a new jobs report published by EP Vantage.